Event log

The following is a list of all job requests run via OpenSAFELY.

OpenSAFELY status

If you are looking for the overall service status, go to our OpenSAFELY Status website.

Status	Project	Workspace	User	Jobs	Backend	Started	View request
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	6 hours ago 16 April 2024 15:32:04 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	6 hours ago 16 April 2024 15:04:51 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	7 hours ago 16 April 2024 14:22:30 UTC	View
Failed	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	25/26	TPP	8 hours ago 16 April 2024 13:41:14 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	8 hours ago 16 April 2024 13:02:09 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	9 hours ago 16 April 2024 12:17:58 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	11 hours ago 16 April 2024 10:40:42 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	12 hours ago 16 April 2024 09:46:36 UTC	View
Failed	Investigating events following SARS-CoV-2 infection	post-covid-renal-v2	Emily Eyles	0/3	TPP	12 hours ago 16 April 2024 09:43:11 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	13 hours ago 16 April 2024 08:56:28 UTC	View
Succeeded	Opioid prescribing trends and changes during COVID-19	opioids-covid-research	Andrea Schaffer	2/2	TPP	13 hours ago 16 April 2024 08:42:05 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	14 hours ago 16 April 2024 07:32:41 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	15 hours ago 16 April 2024 06:45:51 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	16 hours ago 16 April 2024 05:54:45 UTC	View
Succeeded	Opioid prescribing trends and changes during COVID-19	opioids-covid-research	Andrea Schaffer	2/2	TPP	15 Apr 2024 at 19:39 15 April 2024 19:39:02 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	15 Apr 2024 at 19:41 15 April 2024 19:41:28 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	15 Apr 2024 at 18:53 15 April 2024 18:53:22 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	15 Apr 2024 at 18:02 15 April 2024 18:02:00 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	15 Apr 2024 at 15:41 15 April 2024 15:41:29 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	1/1	TPP	15 Apr 2024 at 14:06 15 April 2024 14:06:25 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	15 Apr 2024 at 14:53 15 April 2024 14:53:22 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	15 Apr 2024 at 14:01 15 April 2024 14:01:33 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	15 Apr 2024 at 10:14 15 April 2024 10:14:24 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	15 Apr 2024 at 08:56 15 April 2024 08:56:42 UTC	View
Succeeded	Investigating events following SARS-CoV-2 infection	post-covid-autoimmune-v3	Michael Gulley	26/26	TPP	15 Apr 2024 at 07:32 15 April 2024 07:32:10 UTC	View